Compared with normal tissues, PGAP1, MARK1, and KITLG showed significantly higher expression in patients with NPC, while CRIP1 expression was significantly lower in patients with NPC in both the test and validation datasets. Here, PGAP1 is linked to nasopharyngeal carcinoma.